Nephrocare is aiming to set up 300 Nephrocare centres across the country in the next 8-10 years
Kolkata-based Nephrocare India, a renal care institution founded by renowned nephrologist Dr Pratim Sengupta has announced the successful closure of its pre-IPO round.
The company has raised Rs 8.08 crore in its pre-IPO round. Marquee investors, including Deepak Parekh (veteran banker and former chairman of HDFC Ltd), Bharat Shah (Chairman, HDFC Securities) and Rajendra Agarwal (Founder and MD of Macleods Pharmaceuticals), among others participated in the funding round.
Nephrocare is aiming to set up 300 Nephrocare centres across the country in the next 8-10 years. The company expects to set up 22 high-end comprehensive kidney care facilities across the country by March 2026. Four centres will be opened by the end of the current fiscal year. The company is exploring various options of raising funds, including an IPO. The success of the pre-IPO round is a step forward towards this goal.